Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
D000368:Aged; D001341:Autonomic Nervous System / Q000187:drug effects; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D005080:Exercise Test; D005260:Female; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D007383:Intermittent Claudication / Q000188:drug therapy*; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply; D008297:Male; D009132:Muscles / Q000098:blood supply; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D011868:Radioisotopes; D011928:Raynaud Disease / Q000188:drug therapy*; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014978:Xenon
D009539:Nicotinic Acids; D010919:Placebos; D011868:Radioisotopes; D014665:Vasodilator Agents; D014978:Xenon; D007294:Inositol